HLI:NYSEHoulihan Lokey, Inc. Analysis

Houlihan Lokey is trading at $152.07, just above the calculated support of $146.58 and below the 200‑day SMA of $175.85, indicating limited upside on the price chart. Technical indicators show a neutral trend with the 20‑day SMA ($153.87) above the 50‑day SMA ($149.03), an RSI of 49 (near the midpoint), and a bearish MACD histogram, while volume is increasing, suggesting growing market interest despite mixed signals. The latest quarter delivered earnings of $1.63 per share, missing consensus by 11.5% and showing a QoQ revenue decline of 4.6%, though full‑year revenue rose 9.8% to $2.62 billion, highlighting cyclical pressure on the investment‑banking business. Fundamentally, the firm boasts a strong gross margin of 94%, operating margin of 22%, and a solid ROE of 18%, with a healthy cash position ($1.19 billion) versus modest debt ($0.49 billion) and a dividend yield of 1.84% supported by a 38% payout ratio.
Valuation metrics reveal a trailing P/E of 24.4 versus an industry average of 16.7, suggesting the stock is priced above peers, yet a forward P/E of 16.1 aligns with the sector, and analysts project a median target of $169, implying roughly 13% upside. Sentiment is buoyant, reflected by an “Extreme Greed” fear‑greed index reading of 89.6, but the bearish MACD and recent earnings miss temper short‑term enthusiasm. Overall, the balance of strong fundamentals, modest dividend, and upside potential supports a neutral‑to‑slight‑buy stance for medium‑term investors, while short‑term traders may adopt a cautious hold.